Pymetrozine artificial antigen as well as preparation method and application thereof

By preparing artificial pymetrozine antigens, the problems of high cost and specialized equipment in existing pymetrozine residue detection technologies have been solved, enabling rapid and convenient pymetrozine detection and providing highly specific and sensitive monoclonal antibodies for immunoassay.

CN118955685APending Publication Date: 2024-11-15TAIZHOU FOOD INSPECTION INST +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411044510.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-01
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

Existing methods for detecting pymetrozine residues require expensive equipment and specialized operation, which cannot meet the demand for rapid detection at low cost and large volume. Furthermore, the lack of high-quality antigens and antibodies hinders the application of immunoassay methods.

Method used

Artificial antigens of pymetrozine were prepared by synthesizing pymetrozine haptens and artificial antigens, using mild reaction conditions and simple processing methods to prepare highly specific and sensitive monoclonal antibodies and establish an immunoassay method.

Benefits of technology

It enables rapid, simple, and sensitive detection of pymetrozine, and can efficiently detect pymetrozine residues in crops and agricultural products. It also provides high-quality antibody raw materials to support research and application of immunoassay.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118955685A_ABST
    Figure CN118955685A_ABST
Patent Text Reader

Abstract

The invention provides a pymetrozine artificial antigen preparation method, which comprises: weighing amino triazinone hydrochloride and 5-formyl nicotinic acid, dissolving in absolute methanol, carrying out reflux stirring to prepare a reaction liquid, carrying out suction filtration to collect a creamy white solid, carrying out rotary evaporation on the suction filtration liquid to remove a part of methanol, adding a methanol aqueous solution, carrying out ultrasonic beating, washing, and drying to obtain the pymetrozine artificial antigen. The preparation method comprises the following steps: dissolving pymetrozine into N, N-dimethylformamide (DMF), carrying out suction filtration, collecting a solid, combining the collected solid with the obtained solid to obtain a hapten PYC of pymetrozine, weighing PYC, carbodiimide (EDAC) and N-hydroxysuccinimide (NHS), dissolving the weighed PYC, carbodiimide (EDAC) and N-hydroxysuccinimide (NHS) into N, N-dimethylformamide (DMF), carrying out a stirring reaction to obtain an activated intermediate product of PYC, dissolving bovine serum albumin (BSA) into a 0.13 M NaHCO3 solution, dropwise adding the activated intermediate product of PYC after the reaction into a BSA solution, and carrying out a stirring reaction to obtain a reaction solution; the preparation method comprises the following steps: adding the pymetrozine into a reaction kettle, stirring and reacting at room temperature, putting a reaction solution into a treated dialysis bag, dialyzing in a 0.01 M PBS (Phosphate Buffer Solution) at the temperature of 4 DEG C for 48 hours, changing the solution once every 8 hours, and obtaining the pymetrozine artificial antigen after the dialysis is finished, and the pymetrozine artificial antigen can be applied to the preparation of a kit for detecting pymetrozine.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of food safety immunoassay, and specifically relates to a pymetrozine artificial antigen and a preparation method and application thereof. Background Art

[0002] Pymetrozine (PY), molecular weight is 217.227, CAS number is 123312-89-0, and its structural formula is:

[0003]

[0004] Pymetrozine (PY) is a new type of pyridine insecticide that is particularly effective against piercing-sucking mouthparts pests. When insects come into contact with the agent, they will produce a "mouth needle penetration blockage" effect, causing the insects to starve to death due to food refusal. It can effectively control pests such as aphids, whiteflies, and planthoppers on crops such as wheat, rice, and cotton. PY is widely welcomed by countries around the world because it has no cross-resistance with neonicotinoids. my country widely uses it in agricultural production as a substitute for highly toxic organophosphorus chemical insecticides. However, the residue of PY may endanger human health. PY showed carcinogenicity in toxicity tests. In addition to being harmful to aquatic organisms such as bees, silkworms, and fish, it is also classified as a "potential" human carcinogen. Therefore, countries around the world have made corresponding regulations on the maximum allowable residue level (MRL) of PY in crops. The EU stipulates that the MRL of PY in crops should be lower than 0.02 mg / Kg, and the United States is 0.02-0.6 mg / Kg. my country stipulates that the MRL of PY in wheat is 0.02mg / Kg and in tea is 2mg / Kg. Norway and Canada prohibit the use of PY. Therefore, in order to monitor the residue of PY in crops and their products in real time and protect the health of consumers, it is necessary to establish a fast, simple and efficient detection method.

[0005] At present, the residual detection method of PY is mainly based on instrumental analysis, including high performance liquid chromatography (HPLC), high performance liquid chromatography-tandem mass spectrometry (HPLC-MS / MS), gas chromatography-tandem mass spectrometry (GC-MS), etc. These traditional instrumental analysis methods have the advantages of accurate, stable and reliable detection results. However, they require expensive equipment, professional operators, complex operations, and lengthy pre-treatment procedures, and cannot meet the detection needs of large quantities and low costs. Rapid detection of samples. Therefore, it is necessary to develop a fast and inexpensive method for the detection of PY in a large number of samples. The immunoassay based on antigen-antibody reaction has the advantages of being fast, efficient, sensitive, easy to operate, large analytical capacity, simple sample pre-treatment, and operability by non-professionals. It is suitable for on-site rapid detection of a large number of samples, which is of great significance for the rapid detection of PY. The immunoassay mainly relies on two core reagents, high-quality antigens and antibodies. Therefore, it is necessary to provide a pymetrozine artificial antigen and its preparation method for the preparation of high-quality monoclonal antibodies and the study of immunoassay methods.

[0006] Based on this, an artificial pymetrozine antigen and its preparation method and application were proposed, which can produce highly specific and sensitive antibodies and can be used to establish an immunoassay method for PY. Summary of the invention

[0007] The technical problem to be solved by the present invention is to provide a pymetrozine artificial antigen and a preparation method and application thereof in view of the deficiencies of the above-mentioned prior art, so as to solve the problems raised in the above-mentioned background technology.

[0008] In order to solve the above technical problems, the technical solution adopted by the present invention is:

[0009] In the first aspect, a pymetrozine artificial antigen has the following structure:

[0010]

[0011] In a first aspect, a method for preparing a pymetrozine artificial antigen comprises the following steps:

[0012] S1. Weigh aminotriazine ketone hydrochloride and 5-formylnicotinic acid, dissolve them in anhydrous methanol, and reflux and stir at 66° C. for 8 h to obtain a reaction solution;

[0013] S2, the reaction solution was filtered to collect the off-white solid;

[0014] S3, subjecting the filtrate in S2 to rotary evaporation to remove part of the methanol, adding 25% methanol aqueous solution for ultrasonic pulping, and then filtering, collecting the solid and combining it with the solid in S2 to obtain the hapten PYC of pymetrozine;

[0015] S4, weigh PYC, carbodiimide EDAC and N-hydroxysuccinimide NHS, dissolve them in N,N-dimethylformamide DMF, stir and react at room temperature 22° C. for 12 h to obtain an activated intermediate product of PYC;

[0016] S5, bovine serum albumin BSA was dissolved in 3 mL of 0.13 M NaHCO3 solution, the activated intermediate product of PYC after the reaction was added dropwise to the BSA solution, and the reaction was stirred at room temperature at 220 rpm for 9 h;

[0017] S6. After the reaction is completed, the reaction solution is placed in a treated dialysis bag and dialyzed in 0.01 M PBS solution at 4°C for 48 hours, with the solution changed every 8 hours;

[0018] S7. After dialysis, the precipitate is removed by centrifugation to obtain the pymetrozine artificial antigen, namely PYC-BSA.

[0019] As a further illustration of the present invention, in S1, the amount of aminotriazineone hydrochloride is 252 mg; the amount of 5-formylnicotinic acid is 333 mg; and the amount of anhydrous methanol is 30 mL.

[0020] As a further illustration of the present invention, in S4, PYC is 3.4 mg; NHS is 3.5 mg; EDAC is 6.0 mg; and DMF is 200 μL.

[0021] As a further illustration of the present invention, the BSA in S5 is 10.5 mg.

[0022] In a third aspect, a pymetrozine artificial antigen is used in the preparation of a kit for detecting higenamine.

[0023] Compared with the prior art, the present invention has the following advantages:

[0024] The present invention synthesizes the hapten and artificial antigen of pymetrozine, and the reaction conditions are mild, the synthesis steps and the processing method are simple, and the hapten and artificial antigen of pymetrozine are synthesized, which can be used for the preparation of pymetrozine antibodies and the establishment of immunoassay methods, and provides technical support for subsequent immunoassay research. The monoclonal antibody secreted by the cell line 1G3 obtained based on the pymetrozine artificial antigen has high specificity and good sensitivity to pymetrozine, and the IC 50 =3.8ng / mL, which can be used to determine the content of pymetrozine in crops and agricultural products, and provides raw materials for the immunoassay of PY in agricultural products and other samples, and has practical application value. BRIEF DESCRIPTION OF THE DRAWINGS

[0025] Figure 1 is the reaction formula for synthesizing the pymetrozine artificial antigen of the present invention;

[0026] Figure 2 This is the hydrogen spectrum of the pymetrozine hapten in the embodiment of the present invention;

[0027] Figure 3 This is the SDS-PAGE electrophoresis diagram of the pymetrozine IgG antibody in the embodiment of the present invention;

[0028] Figure 4 This is an SDS-PAGE image of the pymetrozine artificial antigen in an embodiment of the present invention;

[0029] Figure 5 This is the competitive inhibition curve of pymetrozine ic-CLEIA in the embodiment of the present invention;

[0030] Figure 6 It is the structural formula of the pymetrozine artificial antigen in the embodiment of the present invention. DETAILED DESCRIPTION

[0031] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0032] like Figure 1 As shown, the present invention provides a technical solution: a method for preparing a pymetrozine artificial antigen, comprising the following steps:

[0033] S1. Weigh 252 mg of aminotriazine ketone hydrochloride and 333 mg of 5-formylnicotinic acid, dissolve them in 30 mL of anhydrous methanol, and reflux and stir at 66° C. for 8 h to obtain a reaction solution;

[0034] S2, the reaction solution was filtered to collect the off-white solid;

[0035] S3, subjecting the filtrate in S2 to rotary evaporation to remove part of the methanol, adding 25% methanol aqueous solution for ultrasonic pulping, and then filtering, collecting the solid and combining it with the solid in S2 to obtain the hapten PYC of pymetrozine;

[0036] S4, weigh 3.4 mg PYC, 6.0 mg EDAC and 3.5 mg NHS, dissolve in 200 μL DMF, stir at room temperature 22°C for 12 h to obtain an activated intermediate of PYC;

[0037] S5, bovine serum albumin BSA was dissolved in 3 mL of 0.13 M NaHCO3 solution, the activated intermediate product of PYC after the reaction was added dropwise to the BSA solution, and the reaction was stirred at room temperature at 220 rpm for 9 h;

[0038] S6. After the reaction is completed, the reaction solution is placed in a treated dialysis bag and dialyzed in 0.01 M PBS solution at 4°C for 48 hours, with the solution changed every 8 hours;

[0039] S7. After dialysis, the precipitate is removed by centrifugation to obtain the pymetrozine artificial antigen, namely PYC-BSA.

[0040] The identification of the pymetrozine artificial antigen is as follows:

[0041] Prepare 5% stacking gel and 12% separation gel, dilute PYC-BSA and BSA to 0.5 mg / mL, adjust the stacking gel voltage to 90 V and the separation gel voltage to 120 V, perform polyacrylamide gel electrophoresis (SDS-PAGE), stain with Coomassie brilliant blue, and scan the electrophoresis pattern after decolorization.

[0042] Figure 4 This is the SDS-PAGE image of PYC-BSA and BSA. The stained bands are clear and have high aggregation. The band position of PYC-BSA is shifted toward the direction of large molecular weight compared with BSA, indicating that the pymetrozine artificial antigen was successfully prepared and has high purity.

[0043] The preparation of hybridoma cell lines of pymetrozine monoclonal antibodies is as follows:

[0044] After emulsifying PYC-BSA with an equal volume of Freund's adjuvant, 6-8 week old female Balb / c mice were immunized subcutaneously at multiple points in the abdomen. Complete Freund's adjuvant was used for the first immunization, and the immunization dose was 60 μg / mouse; incomplete Freund's adjuvant was used for the booster immunization, and the immunization dose was 60 μg / mouse; booster immunization was performed once every 14 days, and tail vein blood was collected on the 7th day after each immunization, and serum titer was determined by indirect ELISA. After the last booster immunization, serum was collected and serum inhibition was determined by ic-ELISA. After PYC-BSA was diluted with sterile saline, the mice with better inhibition were injected into the tail vein at a dose of 35 μg / mouse.

[0045] Three days after the tail vein injection, the spleen of the mouse was aseptically removed to prepare suspended spleen cells. The spleen cells and SP2 / 0 cells were mixed at a ratio of 1:8, centrifuged to remove the supernatant, and 50% PEG, polyethylene glycol, Mv=4000 was added dropwise within 90s for cell fusion, incomplete DMEM medium was added, and after centrifugation, it was suspended in complete DMEM medium with 20% fetal bovine serum, dispersed into culture bottles, placed in a 37°C 5% CO2 incubator for overnight culture, and then transferred to semi-solid culture medium.

[0046] On the second day of cell fusion, aseptically take the thymus of a 2-3 week old female BALB / c mouse to prepare a thymic cell suspension. Collect the hybridoma cells cultured overnight in the cell culture incubator, centrifuge, discard the supernatant, and add HAT complete medium to suspend the hybridoma cells. Mix the suspended hybridoma cells and feeder cells with the semi-solid culture medium, stir evenly with a pipette, and add the mixed semi-solid culture medium to a 6 cm diameter plate, place it in a 37°C 5% CO2 incubator, observe the growth of the hybridoma cells, and pick out cloned cells around the 13th day.

[0047] Under a microscope, the monoclonal cells grown in the semi-solid culture medium were picked up and cultured in a 96-well cell culture plate containing HT culture medium. The growth of the hybridoma cells was observed every day. When the hybridoma cells grew to more than 40% of the well area, a small amount of cell supernatant was taken for screening. The steps are as follows: the supernatant was tested for positivity by indirect ELISA and the positive wells were screened. Pymetrozine was used as a standard and the competitive inhibition effect of positive cells was detected by indirect competitive ELISA. Cell wells with a high inhibition rate for pymetrozine were selected and subcloned by limiting dilution. The same method was used for screening after 7 days. After repeating the subcloning 3 times, the pymetrozine monoclonal antibody cell line 1G3 was obtained.

[0048] Preparation and application of pymetrozine monoclonal antibody;

[0049] 8-10 week old BALB / c mice were intraperitoneally injected with 0.5 mL of pristane per mouse. Ten days later, 2.0×10 7 Pymetrozine-positive hybridoma cells. Ten days after inoculation, ascites was extracted from the abdominal cavity and purified using a recombinant protein A or G column. After dialysis and desalting, purified pymetrozine monoclonal antibodies were obtained at a concentration of 3.5 mg / mL and stored at -20°C.

[0050] Prepare 2μg / mL PYC-BSA solution with CBS solution, add 100μL / well to 96-well white microplate, incubate overnight at 4℃; discard the liquid in the well, wash the plate 4 times with PBST; add 200μL 5% skim milk to each well for blocking, incubate at 37℃ for 2h, wash once with PBST and dry for use; add 50μL of pymetrozine standards of different mass concentrations and pymetrozine monoclonal antibody diluted in 0.01M PBS (pH 7.4), incubate at 37℃ for 40min; spin dry the liquid in the well, wash 4 times with PBST, add 1:5000 horseradish peroxidase-labeled goat anti-mouse IgG (HRP-IgG) diluted in PBS, 100μL / well, incubate at 37℃ for 40min. After washing the plate 4 times, add 100μL of chemiluminescent substrate to each well, and immediately use a multifunctional instrument to detect the luminescence intensity (RLU) of each well. The binding rate (B / B0) of each concentration was calculated, and a standard curve was established with the logarithm of the mass concentration of pymetrozine as the abscissa and B / B0 (B is the chemiluminescence value (RLU) at different mass concentrations of the standard, and B0 is the RLU when the mass concentration of the standard is 0 ng / mL) as the ordinate.

[0051]

[0052] Determination of IC of pymetrozine monoclonal antibody by ic-CLIEA 50 It was 3.8 ng / mL, indicating that the monoclonal antibody had high specificity and good sensitivity and could be used for immunoassay detection of pymetrozine.

[0053] In this example, the purity of the prepared purified antibody was also tested as follows:

[0054] Prepare 5% stacking gel and 12% separation gel, dilute the purified antibody to 1 mg / mL, adjust the stacking gel voltage to 80 V and the separation gel voltage to 120 V, perform polyacrylamide gel electrophoresis (SDS-PAGE), stain with Coomassie brilliant blue, and scan the electrophoresis pattern after decolorization. Figure 3 This is the SDS-PAGE image of the purified pymetrozine monoclonal antibody. The stained bands are single and clear with high aggregation, indicating that the generated pymetrozine antibody has high purity.

[0055] It can be seen from the above examples that the reaction conditions for the synthesis of the pymetrozine artificial antigen of the present invention are mild, the synthesis steps and the processing method are simple, and it can be used for the preparation of pymetrozine antibodies and the establishment of immunoassay methods, providing technical support for subsequent immunoassay research. The monoclonal antibody secreted by the cell line 1G3 obtained based on the pymetrozine artificial antigen has high specificity and good sensitivity to pymetrozine, IC 50=3.8ng / mL, which can be used to determine the content of pymetrozine in crops and agricultural products, and provides raw materials for immunoassay of PY in samples such as agricultural products, and has practical application value

[0056] It should be noted that, in this article, relational terms such as first and second, etc. are only used to distinguish one entity or operation from another entity or operation, and do not necessarily require or imply any such actual relationship or order between these entities or operations. Moreover, the terms "include", "comprise" or any other variants thereof are intended to cover non-exclusive inclusion, so that a process, method, article or device including a series of elements includes not only those elements, but also other elements not explicitly listed, or also includes elements inherent to such process, method, article or device.

[0057] Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the present invention, and that the scope of the present invention is defined by the appended claims and their equivalents.

Claims

1. A pymetrozine artificial antigen, characterized in that: The structure is as follows:

2. The method for preparing a pymetrozine artificial antigen according to claim 1, characterized in that: The following steps are involved: S1. Weigh aminotriazine ketone hydrochloride and 5-formylnicotinic acid, dissolve them in anhydrous methanol, and reflux and stir at 66° C. for 8 h to obtain a reaction solution; S2, the reaction solution was filtered to collect the off-white solid; S3, subjecting the filtrate in S2 to rotary evaporation to remove part of the methanol, adding 25% methanol aqueous solution for ultrasonic pulping, and then filtering, collecting the solid and combining it with the solid in S2 to obtain the hapten PYC of pymetrozine; S4, weigh PYC, carbodiimide EDAC and N-hydroxysuccinimide NHS, dissolve them in N,N-dimethylformamide DMF, stir and react at room temperature 22° C. for 12 h to obtain an activated intermediate product of PYC; S5, bovine serum albumin BSA was dissolved in 3 mL of 0.13 M NaHCO3 solution, the activated intermediate product of PYC after the reaction was added dropwise to the BSA solution, and the reaction was stirred at room temperature at 220 rpm for 9 h; S6. After the reaction is completed, the reaction solution is placed in a treated dialysis bag and dialyzed in 0.01 M PBS solution at 4°C for 48 hours, with the solution changed every 8 hours; S7. After dialysis, the precipitate is removed by centrifugation to obtain the pymetrozine artificial antigen, namely PYC-BSA.

3. The method for preparing a pymetrozine artificial antigen according to claim 2, characterized in that: In S1, the amount of aminotriazineone hydrochloride is 252 mg; the amount of 5-formylnicotinic acid is 333 mg; and the amount of anhydrous methanol is 30 mL.

4. The method for preparing a pymetrozine artificial antigen according to claim 2, characterized in that: The content of PYC in S4 is 3.4 mg; the content of NHS is 3.5 mg; the content of EDAC is 6.0 mg; and the content of DMF is 200 μL.

5. The method for preparing a pymetrozine artificial antigen according to claim 2, characterized in that: The BSA content in S5 is 10.5 mg.

6. Use of the pymetrozine artificial antigen according to claim 1 in preparing a kit for detecting pymetrozine.